ARS Pharmaceuticals (NASDAQ:SPRY) partners with ALK to co-promote neffy, an epinephrine nasal spray, to 9,000 pediatricians.

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

Seasonal allergies are on the rise, but you don't need to suffer through them. With medications and lifestyle modifications, you can nip allergy symptoms in the bud.